Albert Labs International (XCNQ:ABRT) Asset Impairment Charge : C$0.00 Mil (TTM As of Sep. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Albert Labs International Asset Impairment Charge?

Albert Labs International's Asset Impairment Charge for the three months ended in Sep. 2023 was C$0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2023 was C$0.00 Mil.

Albert Labs International Asset Impairment Charge Historical Data

The historical data trend for Albert Labs International's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert Labs International Asset Impairment Charge Chart

Albert Labs International Annual Data

Trend

Dec21

Dec22

Asset Impairment Charge

Albert Labs International Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Asset Impairment Charge	Get a 7-Day Free Trial					-	-	-	-	-

Albert Labs International Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Albert Labs International Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Albert Labs International's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Albert Labs International (XCNQ:ABRT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (XCNQ:ABRT) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

N/A

Address

6996, Merritt Avenue, Burnaby, BC, CAN, V5J 4R6

Website

https://www.albertlabs.com

Albert Labs International Corp is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of clinical pathway.

Albert Labs International (XCNQ:ABRT) Headlines

No Headlines